Perceptive

Perceptive

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Perceptive is a specialized service provider in the clinical research ecosystem, offering critical imaging and eClinical solutions. Founded in 2016 and headquartered in London, the company has established itself as a trusted partner by supporting over 11,000 trials and 3,000 preclinical studies. Its core business integrates deep scientific expertise in imaging modalities with robust IRT/RTSM technology to de-risk and streamline clinical development for biopharma sponsors and CROs. The company operates globally, providing end-to-end support from protocol design through regulatory submission.

HematologyCNSRadiopharmaceutical Therapy & TheranosticsMusculoskeletalOncologyRare DiseasesObesity / Weight Loss

Technology Platform

Integrated service platform combining Imaging Core Lab capabilities (with VivoQuant™ analysis software), Preclinical Imaging, and IRT/RTSM (Interactive Response Technology) systems for clinical trial randomization and supply management.

Opportunities

Growth is driven by increasing clinical trial complexity, globalization, and the critical need for high-quality imaging endpoints and efficient supply logistics.
The expansion into high-growth areas like radiopharmaceutical theranostics and obesity presents significant service demand.
Offering integrated imaging and RTSM services provides a cross-selling advantage and positions Perceptive as a strategic, end-to-end partner.

Risk Factors

Faces intense competition from large, full-service CROs and other specialized imaging/RTSM vendors.
Revenue is tied to biopharma R&D spending cycles, making it susceptible to economic downturns.
Operational execution risks, including data integrity failures or regulatory non-compliance, could severely damage its reputation as a 'trusted provider.'.

Competitive Landscape

Perceptive competes in two crowded segments: imaging core lab services (against players like BioClinica, ICON plc, and Clario) and IRT/RTSM services (against providers like YPrime, endpoint Clinical, and solutions from large CROs). Its differentiation is based on deep scientific expertise, a combined service offering, and a strong track record, but it must continually innovate to compete with larger players' scale and resources.